ClinicalTrials.Veeva

Menu

Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia

Johns Hopkins University logo

Johns Hopkins University

Status

Withdrawn

Conditions

Aphasia

Treatments

Device: Active tDCS plus Speech-Language Therapy
Device: Sham plus Speech-Language Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02622945
NA00078932

Details and patient eligibility

About

This study aims to determine whether transcranial direct current stimulation (tDCS) paired with speech-language therapy is more beneficial than speech-language therapy alone in acute and chronic post-stroke aphasia.

Full description

This study aims to determine whether behavioral word-retrieval therapy coupled with anodal tDCS will improve the fluency and name retrieval performance of participants with post-stroke aphasia more efficiently and for greater duration than language therapy alone (i.e. in the sham condition).

tDCS neuronal targets will be selected in this order:

  1. left posterior superior-middle temporal gyrus (an area critical for word retrieval and word comprehension),
  2. left posterior frontal areas found to be responsible for lexical selection if the first area is infarcted, or
  3. right cerebellum (important for learning, and consistently activated in naming task) if both of the other areas are infarcted.

The same areas will be stimulated during the first tDCS and sham periods. If the participant returns for a second period of tDCS and sham with language therapy, the right cerebellum will be stimulated (if it was the only uninfarcted target area investigators will stimulate this area again). For cerebellar stimulation, either anodal or cathodal will be used as studies show that anodal or cathodal stimulation has an effect on cognitive functions.

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinically diagnosed with with post-stroke aphasia and word-retrieval deficits
  • Premorbid speakers of English
  • Diagnosis will be based on neuropsychological testing, language testing (most commonly the Western Aphasia Battery), MRI and clinical assessment
  • Stroke size: any l
  • Location: Left hemisphere strokes only from any etiology.
  • Time since stroke onset: 1 day to 20 years.

Exclusion criteria

  • uncorrected visual or hearing impairment by self report
  • other premorbid neurological disorder affecting the brain
  • any other language-based learning disorder or other neurodegenerative disorder such as Alzheimer's Disease or Primary Progressive Aphasia
  • premorbidly diagnosed with a developmental language disorder
  • Pregnant women will also be excluded

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

0 participants in 2 patient groups

Active tDCS plus Speech-Language Therapy
Experimental group
Description:
Active tDCS will be applied at the beginning of 45min speech-language therapy session and will last for 20 min. Language therapy will be oral and written naming. This is a cross-over study so all participants will receive this arm but the order will be randomized.
Treatment:
Device: Active tDCS plus Speech-Language Therapy
Sham plus Speech-Language Therapy
Sham Comparator group
Description:
Sham tDCS will be applied at the beginning of 45min speech-language therapy session. Language therapy will be oral and written naming. This is a cross-over study so all participants will receive this arm but the order will be randomized.
Treatment:
Device: Sham plus Speech-Language Therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems